Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Qiagen (QGEN) and Alcon (ALC).
Qiagen (QGEN)
Kepler Capital analyst Oliver Reinberg upgraded Qiagen to Buy on March 24 and set a price target of EUR51.00. The company’s shares closed last Thursday at $49.06.
According to TipRanks.com, Reinberg has currently 0 stars on a ranking scale of 0-5 stars, with an average return of -7.1% and a 40.6% success rate. Reinberg covers the Healthcare sector, focusing on stocks such as Siemens Healthineers AG, Fresenius Medical Care, and Koninklijke Philips.
The word on The Street in general, suggests a Hold analyst consensus rating for Qiagen with a $57.02 average price target.
See today’s analyst top recommended stocks >>
Alcon (ALC)
In a report issued on March 24, David Evans from Kepler Capital maintained a Sell rating on Alcon, with a price target of CHF48.00. The company’s shares closed last Thursday at $69.37.
According to TipRanks.com, Evans is ranked #2092 out of 7400 analysts.
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Alcon with a $75.79 average price target.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
